CompletedPhase 2NCT00496262
Human Fibrinogen - Pharmacokinetics
Studying Congenital fibrinogen deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CSL Behring
- Principal Investigator
- Program Director, Clinical R&DCSL Behring
- Intervention
- Human Fibrinogen Concentrate(biological)
- Enrollment
- 15 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2007 – 2008
Study locations (15)
- Contact CSL Behring for facility details, Aurora, Colorado, United States
- Contact CSL Behring for facility details, St. Petersburg, Florida, United States
- Contact CSL Behring for facility details, Chicago, Illinois, United States
- Contact CSL Behring for facility details, Scarborough, Maine, United States
- Contact CSL Behring for facility details, New York, New York, United States
- Contact CSL Behring for facility details, Pittsburgh, Pennsylvania, United States
- Contact CSL Behring for facility details, Cagliari, Italy
- Contact CSL Behring for facility details, Florence, Italy
- Contact CSL Behring for facility details, Milan, Italy
- Contact CSL Behring for facility details, Naples, Italy
- Contact CSL Behring for facility details, Padua, Italy
- Contact CSL Behring for facility details, Palermo, Italy
- Contact CSL Behring for facility details, Rome, Italy
- Contact CSL Behring for facility details, Sassari, Italy
- Contact CSL Behring for facility details, Vicenza, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00496262 on ClinicalTrials.govOther trials for Congenital fibrinogen deficiency
Additional recruiting or active studies for the same condition.